AQIX RS-I - Basic development of a therapeutic formulation for the assessment and regeneration of donor organs otherwise regarded as marginal for transplantation

Lead Participant: Aqix Ltd


Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Lead Participant

Project Cost

Grant Offer

Aqix Ltd, LONDON £267,900 £ 160,740


Freeman Hospital, Newcastle Upon Tyne, United Kingdom £131,843 £ 131,843


10 25 50